WHO ICTRP trial
A study of atezolizumab compared to placebo for subjects with late relapse…
EUCTR2015-005471-24-FR · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2015-005471-24-FR |
|---|---|
| Public title | A study of atezolizumab compared to placebo for subjects with late relapse ovarian cancer receiving a treatment with platinum-basedchemotherapy and bevacizumab. |
| Scientific title | A randomized, double-blinded, phase III study of atezolizumab versus placebo in patients with late relapse of epithelial ovarian, fallopian tube, or peritoneal cancer treated by platinum-based chemotherapy and bevacizumab - ATALANTE : ATezolizumab and Avastin in LAte recurreNT diseasE |
| Primary sponsor | ARCAGY-GINECO |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France;Czech Republic;Finland;Belgium;Spain;Denmark;Austria;Israel;Norway;Germany;Italy;Sweden |
| Conditions | Patients with late relapse of epithelial ovarien cancer, fallopian tube or peritoneal cancer treated with chemotherapy , bevacizumab and a anti PD-L1 MedDRA version: 19.0 Level: PT Classification code 10016180 Term: Fallopian tube cancer… |
| Interventions | Product Name: Atezolizumab Product Code: MPDL3280A Pharmaceutical Form: Solution for infusion INN or Proposed INN: Atezolizumab Current Sponsor code: RO5541267 Other descriptive name: MPDL3280A Concentration unit: mg/ml… |
| Registration date | Apr 27, 2016 |
| Target size | 405 |
| Secondary IDs | GINECO-OV236b;ENGOT |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: